Cite
HARVARD Citation
Sidell, D. et al. (2014). High-Dose Sublesional Bevacizumab (Avastin) for Pediatric Recurrent Respiratory Papillomatosis. Annals of otology, rhinology & laryngology. pp. 214-221. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sidell, D. et al. (2014). High-Dose Sublesional Bevacizumab (Avastin) for Pediatric Recurrent Respiratory Papillomatosis. Annals of otology, rhinology & laryngology. pp. 214-221. [Online].